Gynesonics
Gynesonics, a women’s health company, developed and commercialized Sonata, a first-of-its-kind technology to treat sympotmatic uterine fibroids. The minimally-invasive Sonata system enables transcervical, uterus-preserving, incision-free approaches for both diagnostic and therapeutic applications in gynecology. The company was headquarted in Redwood City, CA (US) and was acquired by Hologic (NASDAQ: HOLX) in 2025.